XLock BioSciences
Milwaukee
About XLock BioSciences
XLock BioSciences develops novel engineered chemokine proteins that have therapeutic utility through well-understood biological mechanisms.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $100.0K
- Last round: Grant (Jan 2022)
- Website: xlockbio.com
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/xlock-biosciences-196828 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.